Get started
Author

Xuesong Gu

Observed names: Gu, Xue-Song, X Gu, X.H. Gu, Xue-Song Gu, Xue‐Song Gu
Observed institutions: Tianjin University of Commerce, Brigham and Women's Hospital, Massachusetts Eye and Ear Infirmary, Salk Institute for Biological Studies, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering Cancer Center, Harvard University, Shandong University, Anhui Medical University, Peking University, Nankai University, VA Boston Healthcare System, Dana-Farber Cancer Institute, Hebrew SeniorLife, Dana-Farber/Harvard Cancer Center, Affiliated Zhongshan Hospital of Dalian University, Center for Systems Biology, Qilu Hospital of Shandong University, Parc Científic de Barcelona, Case Western Reserve University
ORCID: 0009-0007-8465-7593
Observed ORCID: 0009-0007-8465-7593
OpenAlex ID: A5104075256
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
2002 · Nicholas Mitsiades, Constantine S. Mitsiades, et al. · Proceedings of the National Academy of Sciences · 741
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
2003 · Nicholas Mitsiades, Constantine S. Mitsiades, et al. · Blood · 697
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications
2003 · Constantine S. Mitsiades, Nicholas S. Mitsiades, et al. · Proceedings of the National Academy of Sciences · 531
PDF
Gene Signatures of Progression and Metastasis in Renal Cell Cancer
2005 · Jon Jones, Hasan Otu, et al. · Clinical Cancer Research · 448
Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer
2004 · Dimitrios Spentzos, Douglas A. Levine, et al. · Journal of Clinical Oncology · 255
PDF
Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells
2006 · Ulrich Steidl, Frank Rosenbauer, et al. · Nature Genetics · 183
Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
2018 · Claire H. Kim, Shelley S. Tworoger, et al. · Scientific Reports · 169
PDF
NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival
2004 · Luiz F. Zerbini, Yihong Wang, et al. · Proceedings of the National Academy of Sciences · 153
Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms
2022 · Danielle E. Haslam, Jun Li, et al. · PROTEOMICS · 151
The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
2012 · J D Paccez, G J Vasques, et al. · Oncogene · 141
Tie2 protects the vasculature against thrombus formation in systemic inflammation
2018 · Sarah J. Higgins, Karen De Ceunynck, et al. · Journal of Clinical Investigation · 127
PDF
Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor α in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor κB–mediated induction of the Ets transcription factor ESE‐1
2003 · Franck Grall, Xuesong Gu, et al. · Arthritis & Rheumatism · 112
ESE-3, a Novel Member of an Epithelium-specific Ets Transcription Factor Subfamily, Demonstrates Different Target Gene Specificity from ESE-1
2000 · Koen Kas, Eduardo Finger, et al. · Journal of Biological Chemistry · 109
Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells
2007 · Xuesong Gu, Luiz F. Zerbini, et al. · Cancer Research · 103
PDF
Characterization of ESE-2, a Novel ESE-1-related Ets Transcription Factor That Is Restricted to Glandular Epithelium and Differentiated Keratinocytes
1999 · Peter Oettgen, Koen Kas, et al. · Journal of Biological Chemistry · 100
PDF
Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl
2019 · Juliano D. Paccez, Kristal Duncan, et al. · Oncogenesis · 81
PDF
Nna1 Mediates Purkinje Cell Dendritic Development via Lysyl Oxidase Propeptide and NF-κB Signaling
2010 · Jianxue Li, Xuesong Gu, et al. · Neuron · 77
PDF
The Ets transcription factor ESE‐1 mediates induction of the COX‐2 gene by LPS in monocytes
2005 · Franck T. Grall, Wolf C. Prall, et al. · FEBS Journal · 66
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
2014 · Luiz Fernando Zerbini, Manoj K. Bhasin, et al. · Molecular Cancer Therapeutics · 65
ESE-1 Is a Novel Transcriptional Mediator of Angiopoietin-1 Expression in the Setting of Inflammation
2004 · Courtney Brown, John Gaspar, et al. · Journal of Biological Chemistry · 62
Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy
2011 · Luiz F. Zerbini, Rodrigo E. Tamura, et al. · PLoS ONE · 60
PDF
Site-Specific In Vivo Calcification and Osteogenesis Stimulated by Bone Sialoprotein
2006 · Jinxi Wang, Hai-Yan Zhou, et al. · Calcified Tissue International · 60
ESE‐1 is a potent repressor of type II collagen gene ( COL2A1 ) transcription in human chondrocytes
2007 · Haibing Peng, Lujian Tan, et al. · Journal of Cellular Physiology · 59
A Novel Pathway Involving Melanoma Differentiation Associated Gene-7/Interleukin-24 Mediates Nonsteroidal Anti-inflammatory Drug–Induced Apoptosis and Growth Arrest of Cancer Cells
2006 · Luiz F. Zerbini, Akos Czibere, et al. · Cancer Research · 59
Tel-2 Is a Novel Transcriptional Repressor Related to the Ets Factor Tel/ETV-6
2001 · Xuesong Gu, Bong-Ha Shin, et al. · Journal of Biological Chemistry · 52
PDF
Works count: 89
Citation count: 5,359
H-index: 33
I10-index: 48
Year
Topic
Type